On March 18, 2024, SymBio Pharmaceuticals Limited closed the transaction. The company amended the terms of the transaction and issued 1,350,000 common shares at an issue price of ¥190 per share for the gross proceeds of ¥256,500,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
172 JPY | -1.15% | -3.37% | -30.36% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.36% | 51.22M | |
+26.08% | 681B | |
+21.85% | 556B | |
-4.77% | 361B | |
+16.97% | 325B | |
+5.69% | 285B | |
+13.68% | 235B | |
+3.65% | 199B | |
-11.12% | 189B | |
-3.40% | 157B |
- Stock Market
- Equities
- 4582 Stock
- News SymBio Pharmaceuticals Limited
- SymBio Pharmaceuticals Limited amended terms of the transaction